v. 3.2 everyone, after the end of the second phase, we will start the third phase clinical trial soon, and the number of people will be larger by then

Aren't many experts saying that the effect of his drug is exaggerated, and that it will inevitably have serious side effects?

He wants to see what those people say after the second phase of the clinical trial is over!

And because the old Wu's condition was cured, the above also gave this medicine a green channel.

After the end of Phase II, Phase III clinical trials will be allowed as quickly as possible, and the production approval process will also be simplified.

The goal is to treat more patients earlier.

This medicine will allow Fu Liang to gain both fame and fortune in the future!

After foreign netizens know that this medicine has oriental clinical effects, they are all fried.

Many family members of patients joined forces to get a petition and sent it to the Food Supervision Bureau in their home country.

PS: Ask for flowers, ask for evaluation, ask for automatic subscription! !

Rear

Chapter [-]: He dares to reject our US FDA?

US FDA (Food v Supervision Bureau) headquarters, their director Butler is sipping coffee

A beautiful blond walked into his office,

With a twist, an intriguing smile appeared on Butler's face.

"Is there any important work today? Let's eat French food together after get off work?

The beauty put the document in her arms on the table: "Mr. Butler, I'm afraid not today, my husband is back from a business trip.

"You'd better deal with the document first, this document needs urgent processing,

With a look of regret, Butler opened the folder lazily. He wanted to see if there were any files worthy of urgent treatment.

Normal official documents have flexible processing time. Even if they are sent to him, there are still a few days for him to read, unless something major happens.

"Huh? Petition? What is this?"

Send the petition to the political axe, send them to the FDA for what?

He glanced at the female secretary in surprise and continued to read the petition.

, 11 is really ridiculous, new drugs are applied for clinically according to normal procedures, and they approve them as appropriate, which company does this

It turned out to be a petition for a new drug clinical trial.

No rules, got a petition, is it a threat?

"Don't send this kind of thing to my office in the future!

Butler simply tossed the petition aside.

But that afternoon, he received a call, and the man scolded him on the phone.

"Didn't you see the petition? Approval or not, why don't you give the public an explanation, do you want me to help you take the blame?

Only then did Bart Qin know that this incident had already had such a big impact,

He would like to explain that the petition says that this is a brain speciality that can treat Alzheimer's disease, brain atrophy, brain stem atrophy and other diseases.

Efficacy.

This is simply not possible!

He has been a police officer for so many years, and he has never heard of any company that has successfully developed such drugs, let alone an eastern pharmaceutical company.

What's more, the second phase of the clinical trial in the East has not yet ended. There is no way to verify the safety. How can it be placed on their side for clinical trials?

And that company didn't apply, should I take the initiative to invite the other party for clinical practice?

We are the FDA, and pharmaceutical companies have always been begging us for quick approval, but none of us took the initiative to beg pharmaceutical companies!

But now that the order has been given, if he doesn't do this, then his good seat may also be lost.

- Next, the other party will obediently send the medicine to the clinic, and maybe even send him a copy

It's just an eastern pharmaceutical company, I believe he hinted a little.

Liu Wu.

Hanging up his boss's phone, he looked at his secretary: "Go to contact this pharmaceutical company and suggest to them that if we bring this drug to the US market for clinical use, we can

for quick approval.

Fu Liang received a call, it was Dr. Edward from Johnson & Johnson.

"Dr. Edward, what's the matter with calling me?" The second phase of the quick stop is almost over, and the third phase has not yet started. The joint venture company is fine.

huh?

"Mr. Xiao Fu, when will the new drug you developed to treat brain atrophy and Alzheimer's disease enter the clinic in the United States?

I'm here to help you get in touch.

, Clinical approval can be obtained at any time.

Fu Liang was a little surprised. In order to maintain cooperation with him, Johnson & Johnson basically did not make money by helping in the clinic, and he had to take some energy.

Not making money is troublesome, why are you so active?

"Edward, this new drug of mine has a domestic phase II clinical trial that has not yet ended, and I am not ready for such a fast clinical trial abroad.

Fu Gao is planning to gradually launch more new drugs to overseas markets.

Now the first hair growth has not been launched, and there is no quick stop. There is no need to do so much at once.

Although top pharmaceutical companies generally have more than a dozen best-selling drugs, Xinming Pharmaceutical has just started, and it is not the strongest in China.

When Dehua heard Fu Liang's refusal, he hesitated and said, "Mr. Xiao Fu, it's actually our country's FDA who actively wants to contact you and ask that the product to be released as soon as possible.

of clinical trials in our country.

"They know that Johnson & Johnson is doing the clinical agency and approval application agency for your new drug in the United States, so they contacted us.

"In fact, although the second phase of the drug's clinical trial has not yet ended, a paper in the journal "Nature" was published on the Internet, causing huge controversy.

sensation.

"Many people have petitioned, hoping that your drug will be clinically available in the United States as soon as possible, their families, and even themselves need this drug for treatment.

When Edward first heard this request, he also thought it was incredible.

Even their Johnson & Johnson company has never had the FDA take the initiative to invite new drug clinical trials.

Fu Liangxin said, it turns out that,

What about Zhou Approval, who doesn't want to beg the cattle, is still stuck in the FDA of Guangguo, and now wants his new drug to be clinically fast?

Isn't it just the American people who put pressure on the US FDA? Does it have anything to do with me? I'm not American!

And although the U.S. market is big, it’s actually not too big. After all, the population base is so small.

For many drugs with similar global sales prices, the United States is only a market that is quite dry in one or two domestic provinces.

"Edward, help me tell the FDA that my application for germination has not been approved yet, let them help.

"After it's done,

, Then my drug can start Phase II clinical trials in the US market at any time.

Edward was stunned for a moment. The FDA took the initiative to invite you to come to the clinic, which is already a great deal of face. You still put forward conditions?

"Mr. Xiaofu,

If you promise now, drugs can be clinically and even marketed faster.

'If I answer the FDA as you say, do you know the consequences?

Fu Liang smiled and asked back: "What are the consequences? Let our medicines not be listed in the United States? I don't care.

Fu Liang has so many special prescriptions in his hand, each of which can make a lot of money, is it a market short of the United States?

Dr. Edward sighed: "Mr. Fu, you really don't think about it anymore?

"Don't think about it, that's my answer.

After hanging up, Edward called Bartchin from the FDA and relayed Fu Liang's answer.

Yan Teqin was stunned.Even European and American pharmaceutical companies would not dare to offend the boss of the US FDA. An Eastern pharmaceutical company would dare to make such a request?

He immediately told the secretary, "Go and see where the Germinal Approval is, and stop for me!

"Also, the company's other clinical trials of new drugs have also stopped. How dare you fight me? Humph!"

PS: Ask for flowers, ask for evaluation, ask for automatic subscription!!!

Chapter [-]: FDA overbearing? I am even more overbearing!

The next day, as soon as Fu Liang went to work, his father called

"Son, our Germinal application is stuck in the U.S. listing.

The Phase III clinical applications, including Supain, were all stuck.

"There are several other drugs in clinical practice that have also been stopped.

"The people at Johnson & Johnson said it was because of you, what happened?

Fu Liang squinted his eyes, the US FDA is playing this game with him? Let's play it and see who will be the first!

"Dad, you don't have to worry about this, I'll let them take the initiative to ask us to go to the clinic again.

"And the application for the card body, they have to pass it obediently!

After a while

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like